Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

80%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Detailed Status

Completed2

Active, not recruiting2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (20.0%)

Phase 24 (80.0%)

Trials by Status

completed240%

active_not_recruiting240%

not_yet_recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

not_yet_recruitingphase_2

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

NCT07501078

active_not_recruitingphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT07501078Phase 2

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

Not Yet Recruiting

NCT05058638Phase 2

Effectiveness of Aquamin® in Mitigating Halitosis

Active Not Recruiting

NCT03869905Phase 2

Aquamin® as an Adjuvant Intervention for Ulcerative Colitis

Active Not Recruiting

NCT04855799Phase 2

GI Permeability Change in Response to Aquamin®

Completed

NCT02647671Phase 1

Aquamin and Prevention of Colon Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5